Results 71 to 80 of about 6,539 (194)
The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome [PDF]
Iranian Journal of Medical Sciences, 2011 Type 2 receptors for vascular endothelial growth factor are believed to be involved in the pathophysiology of ovarian hyperstimulation syndrome (OHSS).
Marzieh Agha Hosseini +4 more
doaj
The Pan African Medical Journal, 2020 Hyperprolactinemia is responsible for 20 to 25% of consultations of secondary amenorrhea and 17% for female infertility. Dopamine agonists are the gold standard treatment of hyperprolactinemia.
Martine Claude Etoa Etoga +8 more
doaj +1 more source
British Journal of Pharmacology, Volume 183, Issue 10, Page 2518-2532, May 2026.Background and Purpose Dopamine receptor agonists, particularly targeting the dopamine D2L receptor (D2LR), have been used to treat Parkinson's disease (PD). However, valvular heart disease and somnolence, mainly caused by activating the serotonin 5‐HT2B receptor (5‐HT2BR) and dopamine D3 receptor (D3R), respectively, currently challenge their clinical
Takayuki Suzuki +4 more
wiley +1 more source
When can we stop cabergoline treatment in prolactinomas? [PDF]
, 2003 Prolactinoma is the most common hormone-secreting pituitary adenoma. The approach to prolactinomas has changed in the past 25 years, thanks to treatment with dopamine agonists, which is characterized by a potent prolactin inhibitory effect, a tumor ...
A. Colao +4 more
core +1 more source
Successful Management of a Giant Pituitary Lactosomatotroph Adenoma Only with Cabergoline
Case Reports in Endocrinology, 2013 Although advances in endocrinologic and neuroradiologic research allow easier recognition of pituitary adenomas, giant pituitary tumours are relatively rare.
Emre Bozkirli +5 more
doaj +1 more source
DRD2 Deficiency Underlies Pituitary Adenoma Dependent on Escherichia coli Translocation from the Gut
Advanced Science, Volume 13, Issue 24, 27 April 2026.Dopamine receptor D2 (DRD2) deficiency disrupts epithelial barrier integrity in both the gut and pituitary gland, facilitating translocation of gut‐derived Escherichia coli into pituitary tissue. Intratumoral E. coli are phagocytosed by microglia, triggering GSDMD‐dependent pyroptosis and HMGB1 release, which subsequently activates MAPK signaling to ...
Xian‐jun Su +16 more
wiley +1 more source
Is Cabergoline Safe and Effective for Postpartum Lactation Inhibition? A Systematic Review
International Journal of Women's Health, 2020 Yang Yang,1 Isabelle Boucoiran,2 Karen J Tulloch,3 Vanessa Poliquin4 1University of Manitoba, Winnipeg, MB, Canada; 2Department of Obstetrics & Gynecology, Université de Montréal, Montreal, QC, Canada; 3BC Women’s Hospital ...
Yang Y +3 more
doaj
Arthritis &Rheumatology, Volume 78, Issue 4, Page 985-992, April 2026.Objectives The aim of this study is to generate hypotheses about unknown drugs associated with the onset or worsening of Raynaud's phenomenon (RP) and to explore their potential pathophysiologic mechanisms through a mixed disproportionality/clustering analysis from the World Health Organization (WHO) pharmacovigilance database.
Alex Hlavaty +4 more
wiley +1 more source
Hiperprolactinemia em pacientes femininas: estudo de seis casos. [PDF]
, 1999 Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Departamento de Tocoginecologia, Curso de Medicina, Florianópolis ...
Martins, Angelo Francisco
core
Oncosexology: A Narrative Review on Sexual Health and Quality of Life in Cancer Patients
Cancer Medicine, Volume 15, Issue 4, April 2026.ABSTRACT Cancer remains a major global public health problem. A key aspect of cancer care among survivors is sexual health. Cancer patients experience a range of sexual dysfunctions, including erectile dysfunction, vaginal dryness, dyspareunia, and reduced libido.
Pasquale Marino +8 more
wiley +1 more source